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Optimal maturation of oocytes and successful development of preimplantation embryos is essential for reproduction. We performed DNA
microarray analyses of ovarian transcripts and identified glial cell line-derived neurotrophic factor (GDNF) secreted by cumulus, granulosa, and
theca cells as an ovarian factor stimulated by the preovulatory LH/hCG surge. Treatment of cumulus–oocyte complexes with GDNF enhanced
first polar body extrusion with increase in cyclin B1 synthesis and the GDNF actions are likely mediated by its receptor GDNF family receptor-
alpha1 (GFRA1) and a co-receptor ret proto-oncogene (Ret), both expressed in oocytes. However, treatment with GDNF did not affect germinal
vesicle breakdown and cytoplasmic maturation of oocytes. During the preimplantation stages, GDNF was expressed in pregnant oviducts and
uteri, whereas GFRA1 and Ret were expressed in embryos throughout early development with an increase after the early blastocyst stage. In
blastocysts, both GDNF and GFRA1 were exclusively localized in trophectoderm cells, whereas Ret was detected in both cell lineages. Treatment
with GDNF promoted the development of two-cell-stage embryos into blastocysts showing increased cell proliferation and decreased apoptosis
mainly in trophectoderm cells. Our findings suggest potential paracrine roles of GDNF in the promotion of completion of meiosis I and the
development of early embryos.
© 2007 Elsevier Inc. All rights reserved.Keywords: Apoptosis; Blastocyst; GFRA1; GDNF; OocyteIntroduction
In vertebrates, rupture of ovarian follicles and final
maturation of oocytes for fertilization occur in response to
stimulation by pituitary-derived LH that acts on the somatic
granulosa and theca cells surrounding the oocyte. Shortly after
stimulation by the preovulatory surge of LH, oocytes arrested at
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doi:10.1016/j.ydbio.2007.12.029vesicle (nuclear envelope) breakdown (GVBD), chromosome
condensation, and extrusion of the first polar body in
preparation for fertilization and early embryonic development.
Recent studies demonstrated that the endocrine hormone LH
stimulates ovarian production of epidermal growth factor
(EGF)-like factors from granulosa cells and insulin-like 3
(INSL3) from theca cells to promote GVBD (Kawamura et al.,
2004; Park et al., 2004). In addition to nuclear maturation
exemplified by GVBD and extrusion of the first polar body to
complete the first meiotic division, oocytes also undergo
cytoplasmic maturation characterized by cytoplasmic changes
essential for monospermic fertilization, processing of the sperm,
and preparation for development to preimplantation embryos
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also stimulate granulosa cells to produce brain-derived
neurotrophic factor (BDNF) that is capable of promoting first
polar body extrusion and the cytoplasmic maturation of oocytes
(Kawamura et al., 2005c). After the conditioning of the oocyte
in preparation for fertilization and preimplantation development
by ovarian factors, a number of growth factors and cytokines
further act as paracrine and/or autocrine factors during early
embryonic development (Brison and Schultz, 1998; Dey et al.,
2004; Hardy and Spanos, 2002).
We performed DNA microarray analyses using ovaries
following gonadotropin stimulation and identified candidate
ligand–receptor pairs potentially involved in the process of
oocyte maturation (Kawamura et al., 2005c). Among different
candidate genes, we found major increases in the ovarian
expression of glial cell line-derived neurotrophic factor (GDNF)
during the preovulatory period. GDNF was first identified as a
survival factor for several types of neurons (Airaksinen and
Saarma, 2002; Lin et al., 1993). GDNF acts through a two-
component receptor system consisting of the ligand-specific
binding subunit, GDNF family receptor-alpha1 (GFRA1) and
the common signal transduction subunit, ret proto-oncogene
(Ret) (Saarma and Sariola, 1999). Although GDNF and its
receptor system are expressed in the nervous system, their
expression has also been detected in several peripheral tissues,
including ovary and testis (Trupp et al., 1995). In the testis,
GDNF contributes to paracrine regulation of spermatogonial
self-renewal and differentiation (Meng et al., 2000) and acts as
the primary growth factor supporting self-renewal of sperma-
togonial stem cells in mice (Brinster, 2007). However, few
studies have explored the roles of GDNF in oocyte maturation
and early embryonic development.
Here, we demonstrated the preovulatory increases of GDNF
transcripts and proteins in ovarian cumulus, granulosa, and
theca cells, and the expression of its receptors, GFRA1 and Ret,
in mouse oocytes. Treatment of cultured oocytes with GDNF
enhanced first polar body extrusion, but not GVBD and the
competence of oocytes to complete preimplantation develop-
ment. We also demonstrated the expression of GDNF, GFRA1,
and Ret in preimplantation embryos and pregnant oviducts and
uteri of mice. Treatment of cultured two-cell-stage embryos
with GDNF promoted their development to blastocysts




Ovarian samples were obtained from female B6D2F1 mice at 25 days of age
(CLEA Japan, Tokyo, Japan) during treatment with a single i.p. injection of 7 IU
of pregnant mare serum gonadotropin (PMSG; Calbiochem, Cambridge, MA)
followed at 48 h later with 10 IU of human chorionic gonadotropin (hCG;
ASKA Pharmaceutical, Tokyo, Japan) administrated i.p. To obtain preimplanta-
tion embryos, B6D2F1 mice treated sequentially with PMSG and hCG were
allowed to mate immediately after hCG treatment. At 46–47 h after hCG
injection, two-cell-stage embryos were obtained by flushing the oviducts of
mated mice for in vitro culture as described (Kawamura et al., 2005a). Oviducts
and uteri were obtained from immature untreated mice, mice treated with PMSG(7 IU), mice treated with PMSG followed 12 h later by hCG (10 IU) treatment,
and from animals at 2 and 4 days after mating. The care and use of animals was
approved by the Animal Research Committee, Akita University School of
Medicine.
DNA microarray analyses
Female B6D2F1 mice (n=108) were injected at 21 days of age with
Humegon (7.5 IU per animal, Organon, Oss, Netherlands) containing follicle-
stimulating hormone and LH activities to stimulate follicular growth. Forty-
eight hours later, some animals were treated i.p. with Pregnyl (5 IU per
animal, Organon) containing LH activity to induce ovulation. Ovaries were
dissected from animals killed bi-hourly after Humegon treatment (three mice
per group) and hourly after Pregnyl treatment (one mouse per group) for
RNA extraction (TRIzol; Invitrogen, Carlsbad, CA). Aliquots of 6 μg of total
RNA at 1 μg/μl for one-chipset hybridization were stored at −80 °C.
Samples were hybridized to the Affymetrix mouse MGU74v2 arrays A, B,
and C (Affymetrix, Santa Clara, CA) according to standard Affymetrix
protocols. The pooled follicular phase samples were hybridized in duplicate,
and the post Pregnyl samples were single determinations (Kawamura et al.,
2005c).
RT-PCR
For quantitative real-time RT-PCR, germinal vesicle (GV) stage oocytes,
cumulus cells, and mural granulosa cells were collected from ovaries of
PMSG-treated immature mice at 48 h after treatment (Kawamura et al., 2005c).
Cumulus–oocyte complexes (COCs) were obtained by puncturing the largest
follicles of preovulatory ovaries, and denuded oocytes (DOs) were separated
from cumulus cells by mechanical pipetting. Granulosa cells were obtained
separately by puncturing preovulatory follicles, followed by the removal of
COCs. Two-cell-stage embryos were obtained by flushing the oviducts of
mated mice at 46–47 h after hCG injection for in vitro culture as described
(Kawamura et al., 2005a). Embryos were allowed to continue development to
different stages and were then collected after culturing in individual microdrops
for 50–52 h (four-cell), 59–60 h (eight-cell), 70–72 h (morula), 94–96 h (early
blastocyst), 119–120 h (expanded blastocyst), and 142–144 h (hatched
blastocyst) after hCG injection.
Quantitative real-time RT-PCR of transcript levels in ovarian cells,
preimplantation embryos, whole ovaries, oviducts, and uteri was performed
using a SmartCycler (Takara, Tokyo, Japan) (Kawamura et al., 2005a,c,
2007). The primers and hybridization probes for real-time RT-PCR of Gdnf,
Gfra1, Ret, and histoneH2a are as follows: Gdnf: sense 5′-CCAGA-
GACTGCTGTGTATTGC-3′, antisense 5′-GGTGGCTACCTTCCTCCTTC-
3′, probe 5′–6-carboxy-fluorescein (FAM)-GGCGGAGGCAGAGGCAGAA-
GAAGAG-6-carboxy-tetramethyl-rhodamine (TAMRA)-3′; Gfra1: sense 5′-
CAGATCTCGCCTTGCAGATT-3′, antisense 5′-GGAGGCAGTCTGCG-
TAGTTC-3′, probe 5′-FAM-TTACCAACTGCCAGCCAGAGTCAAG-
TAMRA-3′; Ret: sense 5′-TGGCACACCTCTGCTCTATG-3′, antisense 5′-
GATGCGGATCCAGTCATTCT-3′, probe 5′-FAM-TCTCTATGGCGTC-
TACCGTACACGG-TAMRA-3′; histone H2a: sense 5′-ACGAGGAGCT-
CAACAAGCTG-3′, antisense 5′-TATGGTGGCTCTCCGTCTTC-3′, probe
5′-FAM-AACATCCAGGCCGTGCTGCT-TAMRA-3′. To determine the
absolute copy number of target transcripts, cloned plasmid cDNAs for
individual gene were used to generate a calibration curve. Purified plasmid
cDNA templates were measured, and copy numbers were calculated based
on absorbance at 260 nm. A calibration curve was created by plotting the
threshold cycle against the known copy number for each plasmid template
diluted in log steps from 105 to 101 copies. Each run included standards of
diluted plasmids to generate a calibration curve, a negative control without a
template, and samples with unknown mRNA concentrations. Data were
normalized based on histone H2a transcript levels (Robert et al., 2002).
For conventional RT-PCR to study cell types expressing specific genes,
primers for β-actin were used as described (Kawamura et al., 2003). PCR
reactions comprised of 35–40 cycles of amplification with denaturation at 94 °C
for 30 s, annealing at 60 °C for 30 s, and elongation at 72 °C for 30 s. For
positive controls, mouse ovary cDNAwas amplified. For negative controls, no
mRNAwas included.
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Inner cell mass and trophectoderm cells were isolated by immunosurgery as
described (Kawamura et al., 2005a). After zona removal and lysis using acid
Tyrode's solution (Sigma, St. Louis, MO), blastocysts were incubated
sequentially at 37 °C in rabbit anti-mouse serum (Sigma) diluted 1:10 in M2
medium (Sigma) for 10 min and then in guinea pig complement serum (Sigma)
diluted 1:3 in M2 medium with 10% fetal bovine serum (FBS) for 30 min. The
lysed trophectoderm cell fraction was subjected to RNA extraction. To remove
residual trophectoderm cells, the inner cell mass was washed through small-bore
glass pipettes before RNA extraction. A total of 15–20 blastocysts was used to
isolate each cell fraction, and total RNAwas extracted using a RNeasy Micro kit
(QIAGEN, Tokyo, Japan) before RT-PCR to determine the spatial expression of
Gdnf, Gfra1, and Ret in the blastocysts. To confirm purity of specific cell
preparations, RT-PCR was performed to detect the inner cell mass marker, Oct-4
(Palmieri et al., 1994) and the trophectoderm marker, urokinase plasminogen
activator (uPA) (Robertson et al., 2001).
ELISA and immunohistochemistry
For ELISA, mouse ovaries were homogenized in a buffer containing
137 mM NaCl, 20 mM Tris–HCl, 1% Nonidet P40, 10% glycerol, and a
protease inhibitor cocktail (Roche Applied Science, Indianapolis, IN) before
centrifugation at 8000×g for 5 min at 4 °C. The supernatant was removed and
stored at −80 °C until use. Levels of GDNF were quantified using the GDNF
Emax immunoassay system (Promega, Madison, WI) after sample thawing
and centrifugation at 8000×g for 5 min at 4 °C. The supernatant was diluted
1:4 in PBS for protein determination using the DC Protein Assay kit (Bio-
Rad, Hercules, CA). The GDNF ELISA was performed by using 96-well
plates coated with a mouse monoclonal anti-GDNF antibody as a capture
antibody. A chicken anti-human GDNF polyclonal antibody was used as the
primary antibody. The sandwich complex was detected by using an anti-
chicken IgY-horseradish peroxidase conjugate, and tetramethylbenzidine was
used as the substrate for colorimetric analysis. The reaction was stopped with
1 M HCl before measuring the absorbance at 450 nm. The results were
normalized by protein concentrations and expressed as pg of GDNF per mg of
ovary.
To localize GDNF, ovaries were obtained from PMSG-primed mice at 4 h
after hCG injection, whereas oviducts and uteri were obtained from pregnant
mice at 4 days after mating. After fixation with Bouin's solution for 1 h at
room temperature before transfer to 70% ethanol, tissues were embedded in
paraffin and sectioned at 3-μm intervals. After deparaffinization and
dehydration, slides were subjected to antigen retrieval with microwave
heating in 10 mM citrate buffer (pH 6) for 5×3 min. Endogenous peroxidase
activities were quenched with 0.3% hydrogen peroxidase-methanol for
30 min. After blocking with 10% bovine serum albumin (BSA)-PBS for
30 min, slides were incubated with rabbit anti-GDNF polyclonal antibodies
(Abcam, Cambridge, UK) at 1:100 dilution overnight at 4 °C. After three
washes in Tris-buffered saline (TBS), slides were incubated with biotinylated
anti-rabbit secondary antibodies (Zymed Laboratories, San Francisco, CA) for
30 min at room temperature. After three washes, bound antibodies were
visualized using a Histostain SP kit (Zymed Laboratories). For negative
controls, the primary antibody was replaced by nonimmune rabbit IgG (Dako,
Carpinteria, CA).
Immunostaining of GDNF was performed using mouse blastocysts as
described (Li et al., 2005). Embryos were fixed with 4% paraformaldehyde
(Electro Microscopy Sciences, PA) and then permeabilized in PBS with 0.1%
Triton X-100 (Sigma) for 10 min at room temperature. After blocking with
Image-iT FX signal enhancer (Invitrogen), embryos were incubated with the
anti-GDNF antibodies in 1% BSA-PBS at 1:100 dilution overnight at 4C. After
three washes in 1% BSA-PBS, embryos were incubated with Alexa Flour-488
donkey anti-rabbit IgG (Invitrogen) in 1% BSA-PBS at 1:1,000 dilutions for 1 h
at room temperature followed by three additional washes. Counterstaining was
performed for 30 min using 1 μg/ml of Hoechst 33342 dye (Invitrogen). After
five washes in PBS, embryos were analyzed under a confocal laser-scanning
microscope (SP2 AOBS, Leica, Wetzlar, Germany). For negative controls, the
primary antibody was replaced by nonimmune rabbit IgG (Alpha diagnostic Intl,
San Antonio, TX).Follicle cultures
Preovulatory follicles were excised from mouse ovaries at 48 h after PMSG
treatment and cultured to examine nuclear maturation of oocytes (Kawamura et
al., 2004). Follicles (20–30 per vial) were treated with or without recombinant
human GDNF (Pepro-Tech, Rocky Hill, NJ) or 5 μg/ml LH (Organon, Oss,
Netherlands) in Leibovitz's L-15 medium (Invitrogen). The doses of GDNF
chosen for these experiments were based on the results of COC model described
below. The vials were flushed at the start of the culture with O2/N2 (at a 1:1
ratio), sealed, and cultured at 37 °C with gentle shaking for 8 h. After culture,
COCs were isolated, and, after cumulus cell removal, oocytes were examined for
the occurrence of GVBD under a Hoffman modulation contrast microscopy
(Nikon Inc., Tokyo, Japan).
Evaluation of first polar body extrusion
Either COCs or DOs were cultured with or without GDNF to evaluate the
effect of GDNF on the transition from metaphase I stage to metaphase II (MII)
stage oocytes. The doses of GDNF chosen for the present studies were based on
the levels of GDNF found in human follicular fluid (0.4–10.8 ng/ml, Kawamura
et al., unpublished data) and those of other ovarian paracrine factors used in
oocyte maturation studies (Kawamura et al., 2005c; Park et al., 2004). COCs and
DOs were obtained from mouse ovaries at 48 h after PMSG treatment as
described above. After washing, COCs or DOs were transferred to M16 medium
(Sigma) without FBS, and cultured with or without GDNF for 24 h at 37 °C in
5% CO2/95% air. Some COCs were also cultured with or without GDNF in the
absence or presence of a neutralizing anti-GDNF antibody (R&D Systems,
Minneapolis, MN) or nonimmune goat IgG (Dako). In addition, some COCs
were cultured without or with 30 ng/ml GDNF, 3 ng/ml BDNF or 30 ng/ml
GDNF in the presence of 3 ng/ml BDNF (Kawamura et al., 2005c). The
occurrence of first polar body extrusion in the oocyte was examined after
removing cumulus cells by using a small-bore pipette.
COC cultures and immunoblotting analyses
COCs were cultured with or without GDNF to measure the levels of cyclin
B1 in oocytes by immunoblotting. COCs were obtained from mouse ovaries at
48 h after PMSG treatment and cultured with or without 30 ng/ml GDNF as
described above. After 7 h of treatment, cumulus cells were removed and the
metaphase I (MI) oocytes were collected for immunoblotting (Kawamura et al.,
2000). Fifty oocytes were homogenized in a buffer containing 137 mM NaCl,
20 mM Tris–HCl, 1% Nonidet P40, 10% glycerol, and a protease inhibitor
cocktail. Samples were boiled for 3 min, and separated by electrophoresis under
reducing conditions on 10% polyacrylamide gels and transferred to poly-
vinylidene difluoride membranes pre-incubated for 1 h in blocking buffer
containing 5% nonfat dry milk. The membranes were incubated with anti-cyclin
B1 monoclonal antibodies (Cell Signaling Technology, Danvers, MA) overnight
at 4 °C. Following incubation with horseradish peroxidase conjugated anti-
mouse IgG (GE Healthcare, Tokyo, Japan) for 1 h at room temperature, cyclin
B1 was detected using SuperSignal West Pico (Pierce, Rockford, IL). After
removal of antibodies from the membranes by Re-Blot Western Blot Recycling
Kit (Chemicon, Temecula, CA), immunoblotting were repeated using anti-β-
actin monoclonal antibody (Sigma) as described above to normalize the total
amount of protein loaded per well. The relative absorbance of band intensities
was determined by densitometric analyses (GeneTools; Syngene, Frederick,
MD).
In vitro maturation, fertilization, and early embryonic development
To assess the effect of GDNF on the cytoplasmic maturation of preovulatory
oocytes, and a potential complementary roles of BDNF on GDNF actions, we
performed in vitro maturation of oocytes followed by in vitro fertilization as
described (Kawamura et al., 2005c). COCs from PMSG-primed mice were
obtained in the M2 medium supplemented with 0.1% FBS before culturing in
minimum essential media (Invitrogen) supplemented with Earle's salts, 10 μg/
ml streptomycin sulfate, 75 μg/ml penicillin G, and 0.1% FBS in the presence or
absence of 30 ng/ml GDNF, 0.1 ng/ml BDNF, or 30 ng/ml GDNF together with
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chosen from the highest concentrations that did not affect on either nuclear or
cytoplasmic maturation of oocytes when cultured with BDNF alone. After 17 h
of treatment, cumulus cells were removed and the oocytes were examined and
classified according to their developmental stages (GV, MI, or MII). MII oocytes
were inseminated with sperm from B6D2F1males and incubated for 6 h at 37 °C
in 5% CO2/95% air. After in vitro fertilization, fertilized oocytes were
recovered, washed twice, and cultured in human tubal fluid medium
(Chemicon). Twenty-two hours after insemination, two-cell-stage embryos
were collected and cultured in 50 μl drops of M16 medium for 5 more days up to
the blastocyst stage. Embryonic development was monitored daily under the
Hoffman modulation contrast microscopy, and the progression of fertilized eggs
to preimplantation embryos was assessed.
Embryo cultures and apoptosis detection
Two-cell-stage embryos were obtained and groups of 10–12 embryos were
placed in 50 μl drops of M16 medium with or without GDNF and covered by
mineral oil. Embryos were cultured for 96 h up to the hatched blastocyst stage
with fresh medium replacement every 24 h. Some embryos were cultured with or
without GDNF in the absence or presence of the neutralizing anti-GDNF
antibody or nonimmune goat IgG. To examine effects of endogenously
produced GDNF on early embryonic development and survival, groups of 40–
45 embryos were cultured in 10 μl drops of M16 medium with or without the
neutralizing anti-GDNF antibody or nonimmune goat IgG. Embryonic
development was monitored after 24, 72, and 96 h of culture to determine the
proportion of embryos at morula, expanded blastocyst, and hatched blastocyst
stages, respectively. At the end of culture, some embryos were subjected to the
TUNEL assay to detect apoptosis as described (Kawamura et al., 2005b).
Evaluation of cell numbers in inner cell mass and trophectoderm
To examine the preferential effect of GDNF on specific cell lineages in
blastocysts, the numbers of inner cell mass and trophectoderm cells in
blastocysts were counted by the differential labeling technique using two
polynucleotide-specific fluorochromes (Kawamura et al., 2003). After staining,
the blastocysts were mounted on a glass slide, and the number of cells in the
inner cell mass and trophectoderm cells in each blastocyst was counted under an
epifluorescence microscope (Olympus Corp., Tokyo, Japan).
Statistical analysis
Statistical analysis was carried out by using Mann–Whitney U test for
paired comparison and the one-way ANOVA followed by Fisher's protected
least significant difference for multiple group comparison. Results are presented
as mean±SEM of at least three separate experiments.Results
Gonadotropin stimulation of the ovarian expression of GDNF
and its receptor Gfra1
We used DNA microarray analyses to identify ovarian
paracrine ligands induced by LH/hCG during the preovulatory
period. As shown in Figs. 1A and B (line graphs), the
expressions of both Gdnf and Gfra1 mRNAs were stimulated
after treatment with Pregnyl containing hCG activity. To
confirm DNA microarray results, we performed real-time RT-
PCR of ovarian transcripts for these genes in mice treated with
PMSG followed by an i.p. injection of an ovulatory dose of
hCG 48 h later. In addition to demonstrating preovulatory
increases in both Gdnf and Gfra1 transcripts in whole ovaries
(Figs. 1A and B, bar graphs), the stimulatory effect of hCG/Pregnyl on ovarian GDNF proteins was detected using ELISA
(Fig. 1C). Treatment with hCG increased more than 2-fold
ovarian GDNF antigen levels at 4 h after hormonal treatment,
followed by a gradual decline.
Ovarian cell types expressing GDNF and the hCG stimulation
of Gdnf and Gfra1 expressions in isolated ovarian cells
The localization of GDNF protein was determined by using
immunohistochemistry. As shown in Fig. 2A, GDNF staining
was observed in cumulus, mural granulosa, and theca cells, but
not in oocytes of preovulatory follicles at 4 h after hCG
treatment. In addition, small antral follicles were not stained
with GDNF (Fig. 2A). In mural granulosa cells, the GDNF
signal was detected in cells surrounding the antrum cavity
(Fig. 2A).
Using isolated ovarian cells, we also examined the
regulation of Gdnf, Gfra1, and Ret transcript levels after hCG
treatment by real-time RT-PCR (Fig. 2B). Although clear
stimulation of Gdnf mRNA was found in cumulus and mural
granulosa cells, levels of this transcript were negligible in
oocytes (Fig. 2B). In contrast, the Gfra1 mRNA was
predominantly expressed in oocytes and cumulus cells from
mice primed with PMSG for 48 h (Fig. 2B). After hCG
treatment, the Gfra1 transcript level was increased in both
cumulus cells and mural granulosa cells, whereas the Gfra1
transcript level remained stable in oocytes (Fig. 2B). The Ret
mRNA showed the highest levels in cumulus cells at 48 h after
PMSG treatment among tested cell types with low levels in the
granulosa cells (Fig. 2B). After hCG treatment, Ret transcript
levels were increased in both cumulus and mural granulosa
cells, but stable in oocytes (Fig. 2B).
Effects of GDNF on the nuclear maturation of preovulatory
oocytes
Based on the hCG stimulation of GDNF expression in
ovarian somatic cells and the expression of GFRA1 and Ret in
oocytes, we tested if GDNF acts as a paracrine factor to
regulate oocyte functions. Because oocytes obtained from
preovulatory follicles underwent spontaneous GVBD when
cultured as COC, we used the preovulatory follicle culture to
test the effect of GDNF on GVBD in oocytes. In cultured
preovulatory follicles, treatment with LH, but not GDNF, for
8 h induced GVBD in oocytes (Fig. 3A). Furthermore,
treatment with GDNF, unlike LH, did not induce cumulus
cell expansion (data not shown). Because preovulatory follicles
are difficult to culture for a prolonged time, we used the COC
model to test the effect of GDNF in promoting further
development of oocytes. As shown in Fig. 3B, treatment with
GDNF increased first polar body extrusion of oocytes in
cultured COCs in a dose-dependent manner. Similar stimula-
tion was evident when DOs were treated with GDNF (Fig. 3C),
indicating a direct effect of GDNF on oocyte receptors. In
addition, the stimulatory effect of GDNF in the COC model
was blocked by cotreatment with the neutralizing anti-GDNF
antibody (Fig. 3D), but not with the nonimmune IgG.
Fig. 1. Gonadotropin stimulation of GDNF expression in mouse ovaries. Gonadotropin regulation of Gdnf (A) and Gfra1 (B) transcripts and the hCG stimulation of
GDNF proteins in ovaries. Line graphs represent DNA microarray data depicting the expression intensity of each transcript (left y axis), whereas bar graphs depict
quantitative real-time RT-PCR results (right y axis; mean±SEM, n=4). Values for expression intensity were derived from integration of hybridization signals from
multiple probe sets for individual genes. (C) Ovarian content of GDNF (μg/g ovarian wet weight) was measured by ELISA (mean±SEM, n=4). For each time point,
four samples prepared from individual animals were used for the real-time RT-PCR or ELISA. *Pb0.01 vs. 0 h of PMSG treatment.
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body alone was ineffective. We further assessed the molecular
mechanism underlying the GDNF promotion of first polar body
extrusion. Because MI phase lasted between 7 and 10 h during
in vitro culture in the oocytes (data not shown), COCs obtained
from preovulatory follicles were cultured for 7 h before
measuring the levels of cyclin B1 proteins in oocytes at MI
phase. Although a 60-kDa antigen corresponding to cyclin B1
was detected in all samples, its levels were increased 2.5-fold
by treatment with GDNF treatment (Fig. 3E).
To explore whether BDNF and GDNF complement each
other in the control of first polar body extrusion, COCs were
cultured with either GDNF or BDNF alone or with GDNF in the
presence of BDNF. Although treatment with GDNF or BDNF
alone promoted first polar body extrusion, the proportion of firstpolar body extrusion in the group cotreated with GDNF and
BDNF was similar to that treated with BDNF alone (Fig. 3F),
suggesting redundant roles of GDNF and BDNF in first polar
body extrusion.
Effects of GDNF on cytoplasmic maturation
The role of GDNF in conditioning the oocytes for
subsequent fertilization and progression to blastocysts was
evaluated in vitro (Fig. 4A). COCs obtained from mice primed
for 48 h with PMSG were cultured with or without GDNF. To
avoid hardening of the zona pellucida that is unfavorable for in
vitro fertilization, 0.1% FBS was included for all cultures.
Similar to serum-free cultures (Fig. 3B), treatment with GDNF
increased the proportion of oocytes showing first polar body
Fig. 2. Localization of GDNF in mouse ovaries and its stimulation by hCG in the cumulus, granulosa, and theca cells. (A) Immunohistochemical detection of GDNF in
ovaries of PMSG-primed mice 4 h after hCG injection. GDNF was found in cumulus (black arrowheads), mural granulosa (white arrowheads), and theca cells (arrows)
of preovulatory follicles. Two lower panels depict sections with nonimmune IgG and serve as controls. (Scale bars, 200 μm.) (B) hCG regulation of Gdnf, Gfra1, and
Ret expression in mouse oocytes (OC), cumulus cells (CC), and mural granulosa cells (GC) at different times after hCG treatment. Transcript levels of Gdnf, Gfra1,
and Ret in isolated ovarian cells were quantified by real-time RT-PCR (mean±SEM, n=5). For each time point, five samples prepared from individual animals were
used. *Pb0.01 vs. 0 h of hCG treatment.
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fertilized in vitro without further treatment with GDNF.
However, pretreatment with GDNF did not increase the
proportions of MII oocytes that developed into the two-cell or
blastocyst-stage embryos (Fig. 4A). Furthermore, we tested if
GDNF stimulates cytoplasmic maturation of oocytes in the
presence of low levels of BDNF. As shown in Fig. 4B,
supplementation of GDNF with low levels of BDNF had no
effect on cytoplasmic maturation, or on the GDNF-promoted
first polar body extrusion.Temporal and spatial expression of GDNF and its receptors,
Gfra1 and Ret in preimplantation embryos
To gain a more complete understanding of the roles of
GDNF and its receptors during early embryonic development,
we further tested the expression of these genes in early
embryos. Quantitative real-time RT-PCR was performed to
examine the temporal expression of Gdnf as well as Gfra1
and Ret receptors in preimplantation embryos. Levels of
Gdnf mRNA were low from the two-cell stage up to the
Fig. 3. GDNF stimulation of first polar body extrusion by cultured preovulatory oocytes. (A) Lack of effects of GDNF on GVBD of oocytes. Preovulatory follicles
were cultured without (control, C) or with LH (5 μg/ml) or GDNF (30–1000 ng/ml) for 8 h before evaluation of oocytes undergoing GVBD (n=3, 61–69 follicles per
experimental group). (B and C) Effects of GDNF treatment on first polar body extrusion by cultured cumulus–oocyte complexes (B; COCs) and denuded oocytes (C;
DOs). COCs or denuded oocytes isolated from preovulatory follicles were cultured without (controls, C) or with GDNF for 24 h. After culture, the percentage of
oocytes showing first polar body extrusion was determined (n≥3, 48–186 oocytes per experimental group). (D) Neutralizing effects of the anti-GDNF antibody on the
GDNF stimulation of first polar body extrusion. COCs were cultured with or without GDNF (30 ng/ml) in the absence or presence of the anti-GDNF antibody or
nonimmune IgG (n≥3, 35–186 oocytes per experimental group). (E) Effects of GDNF treatment on the levels of cyclin B1 protein in MI oocytes. COCs were cultured
without (controls, C) or with GDNF for 7 h. After removal of cumulus cells, oocytes were subjected to immunoblotting. (Upper panel) A representative immunoblot
showing the cyclin B1 protein at 60 kDa and b-actin protein at 42 kDa. (Lower panel) Densitometric analyses of relative expression levels of cyclin B1 protein. The
cyclin B1 levels were represented as fold increases to the control group (mean±SEM, n=3). (F) Effects of BDNF treatment on the GDNF-promoted first polar body
extrusion. COCs were cultured without (controls, C) or with GDNF (30 ng/ml), BDNF (3 ng/ml) or GDNF (30 ng/ml) in the presence of BDNF (3 ng/ml) (n≥3,
72–140 oocytes per experimental group). *, Pb0.01 vs. control group.
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reaching its highest levels in the hatched blastocyst stage
(Fig. 5A, upper panel). In contrast, levels of Gfra1 mRNA
were high in the two-cell-stage embryos and showed adecrease in the eight-cell stage before increasing at the
morula stage to reach the highest levels in the hatched
blastocyst stage (Fig. 5A, middle panel). The temporal
expression of Ret mRNA in preimplantation embryos was
Fig. 4. Lack of effect of GDNF in the conditioning of oocytes for the development into preimplantation embryos. (A) Lack of effect of GDNF on cytoplasmic
maturation of preovulatory oocytes. COCs obtained from preovulatory follicles were cultured without (control) or with GDNF (30 ng/ml) for 17 h. After progression
into the MII stage, oocytes were inseminated and cultured for 5 more days without hormones. The percentage of MII oocytes developing into 2-cell-stage embryos and
the percentage of 2-cell-stage embryos developing into blastocyst-stage embryos were evaluated (n=4, 97–166 oocytes per experimental group). (B) Lack of effect of
GDNF on cytoplasmic maturation of preovulatory oocytes in the presence of low levels of BDNF. COCs were cultured without or with GDNF (30 ng/ml), BDNF
(0.1 ng/ml) or GDNF (30 ng/ml) in the presence of BDNF (0.03 or 0.1 ng/ml) (n≥3, 60–166 oocytes per experimental group). *Pb0.01 vs. controls.
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stages (Fig. 5A, lower panel).
Cells in the inner cell mass and trophectoderm were isolated
for RT-PCR analyses to determine the cell types expressing
Gdnf, Gfra1, and Ret in blastocysts. The Gdnf and Gfra1
transcripts were detected in trophectoderm cells, but not cells in
the inner cell mass. In contrast, Ret mRNAwas expressed both
cell lineages (Fig. 5B). The purity of isolated cells was
confirmed by using Oct-4 and uPA as markers for the inner
cell mass and trophectoderm, respectively. The expression of
GDNF in trophectoderm cells was further confirmed using
immunofluorescent staining (Fig. 5C).
Expression of GDNF in oviducts and uteri during the
preimplantation period
The expression of GDNF in oviducts and uteri was examined
during the preimplantation period. In the oviducts, quantitative
real-time RT-PCR analyses indicated that Gdnf mRNA levels
were high in immature mice at 25 days of age (Fig. 6A, 0 h),
decreased after PMSG treatment, and maintained at low levels
until 12 h after hCG treatment (Fig. 6A). However, Gdnf mRNA
levels increased at days 2 and 4 of pregnancy (Fig. 6A). In theuterus, levels of GDNF transcripts were high in immature mice at
25 days of age (Fig. 6B, 0 h), and decreased after PMSG
treatment, and maintained at similar levels from 12 h after hCG
treatment until day 4 of pregnancy (Fig. 6B). Immunohistochem-
ical analyses further indicated that GDNF were expressed in the
oviductal epithelial cells and the luminal and glandular epithe-
liums of uterine endometrium, but not in stromal cells (Fig. 6C,
upper and middle, GDNF staining; lower, negative controls).
Effects of GDNF treatment on the development of
preimplantation embryos
The expression of GDNF, GFRA1, and Ret in preimplanta-
tion embryos and the production of GDNF in oviduct and uteri
suggest the GDNF/GFRA1-Ret signaling system could play a
role during early embryonic development. We further tested the
effect of GDNF treatment on cultured early embryos. Although
GDNF treatment did not affect the development of two-cell-
stage embryos to the morula stage (data not shown), GDNF
promoted the development of embryos to the expanded and
hatched blastocyst stages evaluated after 72 and 96 h of culture,
respectively (Fig. 7A). The specificity of the effects of GDNF
on preimplantation embryos was examined by using the
Fig. 5. Temporal and spatial expression of GDNF, GFRA1, and Ret in mouse preimplantation embryos. (A) Transcript levels for Gdnf, Gfra1, and Ret in developing
preimplantation embryos were determined using real-time RT-PCR. Levels of all mRNAs were normalized based on those for histone H2a in the same sample
(mean±SEM, n=3). 2C: 2-cell; 4C: 4-cell; 8C: 8-cell; M: morula; B: early blastocyst; EB: expanded blastocyst; HB: hatched blastocyst. *, Pb0.01 vs. 8C. (B)
Spatial expression of Gdnf, Gfra1, and Ret in blastocysts. Oct-4 and urokinase plasminogen activator (uPA) transcripts were used as markers for inner cell mass
(ICM) and trophectoderm (TE), respectively. Levels of β-action served as loading controls. BL: whole blastocyst; NC: negative control. (C) Immunohistochemical
detection of GDNF antigens in blastocysts. (Left panel) Specific GDNF signals are localized in TE cells (arrowheads), but not ICM cells (arrow). (Right panel)
Negative controls. Cell nuclei were stained in blue with Hoechst 33342.
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promote the development of two-cell-stage embryos to the
hatched blastocyst stage was blocked by cotreatment with the
neutralizing anti-GDNF antibody, but not with the nonimmune
IgG (Fig. 7B).
To examine the effect of endogenous GDNF on embryo
development, embryos were cultured at a higher density to
increase the concentration of endogenous GDNF in the culture
medium, and the embryos were treated with the neutralizing
anti-GDNF antibody or the nonimmue IgG alone without
GDNF. Although the proportions of embryos at the hatchedblastocyst stage in the control group were increased following
culture at high density, treatment with the neutralizing anti-
GDNF antibody did not affect on the development of embryos
(control, 75.4±4.2%; anti-GDNF antibody, 72.2±5.0%; non-
immue IgG, 71.1±4.2%).
Effects of GDNF treatment on cell proliferation and apoptosis
of cultured blastocysts
To determine if GDNF acts as a survival factor for early
embryos, we evaluated cell proliferation and apoptosis in
Fig. 6. Expression of GDNF in mouse oviducts and uteri during the preimplantation period. Quantification of Gdnf transcripts in oviducts (A) and uteri (B) using real-
time RT-PCR. Levels of Gdnf mRNAwere obtained at different times after PMSG and hCG treatment. Some samples were obtained from animals at days 2 or 4 of
pregnancy (mean±SEM, n=3). For each stage, three samples prepared from individual animals were used. Levels of Gdnf mRNAwere normalized using transcript
levels of histone H2a in the same sample. *Pb0.01 vs. oviducts from animals treated with PMSG for 48 h and uteri from animals primed with PMSG followed by hCG
treatment for 12 h. (C) Localization of GDNF proteins in oviducts and uteri. Immunohistochemical analyses showed the expression of GDNF antigens in pregnant
oviducts and uteri at 4 days after mating. (Upper) Low magnification. (Middle) High magnification. (Lower) Negative controls. Specific GDNF staining was localized
to oviductal and endometrial epithelial cells, but not stromal, cells. (Scale bars, 100 μm.)
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were cultured for 72 h with GDNF. Because hatched blastocysts
are difficult to retrieve due to extreme viscosity, expanded
blastocysts were used for TUNEL staining. Counting of cells
indicated that GDNF treatment increased the total number ofcells in blastocysts (Figs. 8A and C), and the increase of cell
number was preferentially observed in the trophectoderm (Fig.
8C). Treatment with GDNF also decreased the proportion of
TUNEL-positive nuclei (Fig. 8B), thus suggesting a suppres-
sion of apoptosis. Furthermore, the effects of GDNF on cell
Fig. 7. GDNF promotion of the development of preimplantation embryos. (A) Effects of GDNF treatment on early embryonic development. Two-cell-stage embryos
(10–12 embryos/50 μl culture drop) were cultured without (control, C) or with GDNF for 72 and 96 h to evaluate the proportion of embryos at expanded and hatched
blastocyst stages, respectively (mean±SEM, n≥8, 80–103 embryos per group). (B) Neutralization of the GDNF stimulation of embryonic development by the anti-
GDNF antibody. Two-cell-stage embryos were cultured for 96 h with or without GDNF (10 ng/ml) in the absence or presence of the anti-GDNF antibody or the
nonimmune IgG (mean±SEM, n≥5, 50–103 embryos per group). *Pb0.01 vs. control group.
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neutralizing anti-GDNF antibody, but not with the nonimmue
IgG (Fig. 8B). Similar to studies on early embryonic
development, treatment with the neutralizing anti-GDNF anti-
body alone had no effect on the numbers of cells and TUNEL-
positive nuclei in the blastocysts cultured at high density
without GDNF (cell number: control, 101.3±3.9; anti-GDNF
antibody, 106.3±5.6; nonimmue IgG, 105.2 ±6.2, TUNEL-
positive nuclei: control, 2.37±0.38%; anti-GDNF antibody,
2.19±0.32%; nonimmue IgG, 2.33 ±0.48%).
Discussion
The present study demonstrates the important role of an
ovarian paracrine factor, GDNF, in stimulating first polar body
extrusion. Mammalian oocytes undergo spontaneous GVBD
after removal from surrounding somatic cells, but only a
fraction of them reach the first polar body stage. Although
earlier studies demonstrated the important roles of ovarian EGF-
like factors and INSL3 in GVBD during the preovulatory period
(Kawamura et al., 2004; Park et al., 2004), these factors are notneeded for nuclear envelope breakdown of isolated oocytes
during in vitro culture. In contrast, our previous (Kawamura et
al., 2005c) and the present findings demonstrated that both
BDNF and GDNF are capable of promoting first polar body
extrusion, and their redundant roles in first polar body
extrusion. Although the proportion of spontaneous first polar
body extrusion is different among the mouse strains (Marin
Bivens et al., 2004), GDNF also promoted first polar body
extrusion in Jcl:ICR strain that showed high spontaneous levels
of first polar body extrusion (control, 61.9±3.1%; 30 ng/ml
GDNF, 78.0±5.1%). However, the effects of GDNF were more
evident in the BDF1 mice. Mouse oocytes do not require de
novo synthesis of proteins to undergo GVBD in vitro, whereas
the synthesis of cyclin B1 is indispensable for the progression of
meiotic maturation after GVBD (Hampl and Eppig, 1995;
Polanski et al., 1998). Thus, our data on the increase in cyclin
B1 protein in MI oocytes following GDNF treatment suggest its
contribution to the GDNF promotion of completion of meiosis
I. Although BDNF could condition the eggs for optimal
fertilization and development into preimplantation embryos
(Kawamura et al., 2005c), ovarian GDNF showed no effect on
Fig. 8. Treatment with GDNF increases cell numbers and suppresses apoptosis
in blastocysts. Effects of GDNF treatment on cell number (A) and apoptosis (B)
in blastocysts. Two-cell-stage embryos were cultured for 72 h with or without
GDNF (10 ng/ml) and the specificity of GDNF actions was evaluated by
cotreatment with the anti-GDNF antibody (1 μg/ml). Apoptosis in embryos was
assayed by detecting apoptotic nuclei using TUNEL staining (mean±SEM, total
n=20 embryos per group). (C) Effects of GDNF treatment on the number of
total, TE, and ICM cells in blastocysts. Two-cell-stage embryos were cultured
for 72 h with or without GDNF (10 ng/ml) (mean±SEM, total n=20 embryos
per group.) *Pb0.01 vs. control group.
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present model. A recent study reported that the proportion of
parthenogenetically activated porcine oocytes forming blasto-
cyst was increased after in vitro culture with GDNF (Linher et
al., 2007). In contrast to our experimental setting for oocyte
maturation, LH, FSH, EGF, and 10% porcine follicular fluid
were included in the maturation medium of this study. Thus,
GDNF may require additional hormonal factors and/or
unknown factors present in the follicular fluid for the optimalinduction of the cytoplasmic maturation of oocytes. However,
the low levels of BDNF did not augment GDNF-stimulated
cytoplasmic maturation.
DNA microarray analyses of the ovarian transcriptome
during the preovulatory period allowed us to identify major
stimulation of both GDNF and GFRA1 expressions after the
LH/hCG induction of ovulation. Our findings of presence of
ovarian GDNF in mice are consistent with earlier studies in
rodents (Choi-Lundberg and Bohn, 1995; Golden et al., 1999;
Widenfalk et al., 2000). Ovarian localization of GDNF, GFRA1
and Ret genes, their regulation by hCG and earlier findings of
GDNF proteins in porcine follicular fluid (Linher et al., 2007)
suggested that GDNF produced by ovarian somatic cells in
response to hCG stimuli could act on the GFRA1–Ret receptor
complex that is expressed in the oocyte. Because both GDNF
and its receptors, GFRA1 and Ret, are also expressed in the
cumulus and granulosa cells, their autocrine/paracrine roles in
the cumulus and granulosa cells cannot be ruled out.
Completion of the nuclear maturation of oocytes involves
GVBD and extrusion of the first polar body. Although treatment
of cultured COCs with GDNF did not affect GVBD of oocytes,
it facilitated first polar body extrusion, consistent with an earlier
finding in porcine (Linher et al., 2007). The dose range used in
the present studies was similar to that used in the porcine study
(Linher et al., 2007). Furthermore, the concentrations of GDNF
in human preovulatory follicular fluid were comparable to those
levels. Similar to the BDNF stimulation of first polar body
extrusion, but not GVBD, it is apparent that sequential steps of
nuclear maturation of the oocyte are controlled by different
paracrine factors. Although both cumulus cells and oocytes in
COCs express GFRA1 and Ret receptors, GDNF induced first
polar body extrusion in denuded oocytes, suggesting its direct
effects on oocytes. Our unpublished data showed that GDNF
treatment did not induce cumulus cell expansion in preovulatory
follicles cultured with the serum-free medium. Because a recent
study demonstrated GDNF induction of cumulus cell expansion
of COCs cultured in the medium containing LH, FSH, EGF, and
10% porcine follicular fluid (Linher et al., 2007), GDNF may
support cumulus cell expansion in combination with other
factors.
Our data further showed the expression of Gfra1 and Ret
receptor mRNAs not only in oocytes but also in preimplantation
embryos, and the production of GDNF in the oviductal and
uterine epitheliums. Because preimplantation embryos develop
in the oviduct until day 4 of pregnancy when they reach the late
morula/blastocyst stage before migrating to the uterus, the
increasing levels of GDNF in the oviduct and uterus during days
2 and 4 of pregnancy suggest potential paracrine roles of GDNF
in preimplantation embryo development. In cultured preim-
plantation embryos, the present study further demonstrated the
ability of GDNF to promote early embryonic development and
to suppress embryo cell apoptosis, suggesting the inclusion of
this factor could promote in vitro embryo cultures.
The effect of GDNF to promote blastocyst development is
associated with its ability to inhibit apoptosis and to increase
total cell numbers in blastocysts. Both GFRA1 and the co-
receptor are highly expressed in trophectoderm cells of
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these receptors to promote early embryonic development, to
increase cell numbers in blastocyst, and to prevent blastocyst
cell apoptosis. The apoptosis-suppressing effect of GDNF is
consistent with earlier studies showing the survival actions of
GDNF on neuronal cells (Airaksinen and Saarma, 2002; Lin et
al., 1993). For example, there is a substantial loss of motor
neurons, and a corresponding increase in apoptotic cells, in
GDNF- and GFRA1-deficient mouse embryos (Garces et al.,
2000). Conversely, motor neuron survival is promoted by
overexpression of GDNF or GDNF treatment in utero
(Oppenheim et al., 2000). GDNF also promotes the migration,
proliferation, survival and differentiation of multipotent pre-
cursor cells of enteric nervous system that express GFRA1 and
Ret (Taraviras et al., 1999). The observed exclusive expression
of GFRA1 in trophectoderm cells of blastocysts is consistent
with our findings of a preferential effect of GDNF on the cell
proliferation of trophectoderm cells. Because trophectoderm
cells in blastocysts differentiate during embryonic development
to form the invasive trophoblasts that mediate embryo
implantation into the uterine wall, our findings suggest a
potential involvement of GDNF during implantation.
In addition to the paracrine signaling of GDNF, endogenous
GDNF is also expressed in the trophectoderm cells of
blastocysts. Because the concentration of endogenous hormonal
ligands in the culture medium are higher when embryos are
cultured at high density (Paria and Dey, 1990), the autocrine
roles of GDNF during early embryonic development could be
demonstrated in embryos cultured at high density by treatment
with the neutralizing anti-GDNF antibody without exogenous
GDNF. However, we could not demonstrate stimulating effects
of endogenous GDNF in the embryo development. Because of
the low expression levels of GDNF in the embryos, the
concentration of endogenous GDNF was too low to exhibit its
effects on the embryo development. Thus, in contrast to the
paracrine effects, autocrine roles of GDNF in early embryonic
development may be less important in physiological conditions.
Because mutant mice with defects in GDNF, GFRA1, or Ret
showed similar phenotypes and died at first postnatal day
(Enomoto et al., 1998; Moore et al., 1996; Pichel et al., 1996;
Schuchardt et al., 1994), no female mice were available for
investigating changes in ovarian functions. GDNF preferen-
tially interacts with the receptor complex GFRA1-Ret, but it can
also activate the GFRA2–Ret complex. Although GFRA1 binds
GDNF with high affinity, it also interacts with other GDNF
family members including neurturin and artemin (Saarma and
Sariola, 1999). Because our preliminary data indicated the
expression of Gfra2 transcripts in preimplantation embryos,
and both neurturin and artemin expressions in oviducts and uteri
(data not shown), studies on the role of GDNF during early
embryonic development in pups lacking GFRA1 are compli-
cated due to the overlapping actions of different GDNF family
members and their receptor complexes.
Herein, we have demonstrated the ability of GDNF to
complete meiosis I of preovulatory oocytes and to enhance the
development and survival of preimplantation embryos. It is
becoming clear that this ligand signaling system, originallyfound to be essential for the survival and differentiation of the
neuronal system, is also important for diverse reproductive
processes including the spermatogonial self-renewal and
differentiation (Meng et al., 2000), the cumulus cell expansion
(Linher et al., 2007), the nuclear and cytoplasmic maturation of
oocytes (Linher et al., 2007), and the development of early
embryos. The present demonstration of an augmenting role for
GDNF in the development of oocytes and early embryos
underscores the importance of diverse autocrine/paracrine
systems for oocyte maturation and early embryogenesis.
Understanding of these intercellular communication networks
could lead to new approaches in the treatment of infertility, and
facilitate future formulation for the optimal culture conditions
for in vitro maturation, in vitro fertilization and embryonic stem
cell derivation.
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